Chile

Laboratorios Andromaco S.A. (Penalolen)

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 19.99 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Spanish Format: PDF Download Most recent financial data: 2009 Buy full report

What’s included?

This report extracts all available information about Laboratorios Andromaco S.A. from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
5273 Quilin Blvd.
Penalolen; Metropolitana; Map

Tel: +56-22594-

Email:
@andromaco.cl

Website:
http://www.andromaco.cl

Company Description
With more than 60 years of experience, Andromaco Laboratorios is a Chilean company leader in the production and commercialization of pharmaceutical products of excellence. Representing important international consortiums, it forms a wide and diverse offer of own products and license to cover the health needs of Chile as well as of different countries of the region. The company specializes in ethical or prescription products that meet the requirements of different medical specialties. It also has a wide range of high technology and generic products, as well as OTC or OTC products. Andromaco Laboratories is characterized by the innovative introduction of innovative drugs for the treatment and prevention of different diseases, and actively participates in the research and development of cutting-edge products. It has a production plant for non-hormonal products and another exclusively for hormonal products, in a plot of 25,740 m2 located in the commune of Penalolen. The quality of its products is guaranteed by a double GMP (Good Manufacturing Practices) certification from the Institute of Public Health of Chile; The certification for suppliers of CENABAST and the certification provided by the National Institute of Drug Surveillance (INVIMA) of Colombia. Andromaco Laboratories began operations in Chile in 1942, and already in the first market measurements, carried out from 1977, the company began to figure among the ten most important companies of the sector. The company was absorbed by Inversiones Gruchi in 2014. The latter then took the name of the former becoming itself Laboratorios Andromaco S.A.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
1,375 (2014)
Outstanding Shares:
: ()
Financial Auditors:
()
Incorporation Date:
December 16, 1964
Profile Updated:
September 25, 2017
Key Executives
General Manager
Marketing Manager
Marketing Manager
Key Financial Highlights
2014 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 115,241,080
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: Superintendencia de Valores y Seguros, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

Latest News (Not included in the report)

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO